<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43694">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02108925</url>
  </required_header>
  <id_info>
    <org_study_id>2013/2396</org_study_id>
    <nct_id>NCT02108925</nct_id>
  </id_info>
  <brief_title>Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease Patients</brief_title>
  <official_title>Oxygen Supply and Ventilation During Physical Exercise in Patients With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LHL Helse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LHL Helse</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <authority>Norway: Directorate of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project will test the hypothesis that lung ventilation during exercise is unaffected by
      oxygen supplementation. In addition, the acute effect of oxygen supplementation on dyspnoea,
      heart rate and blood pressure will be studied.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pulmonary ventilation</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnoea</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>Supplementary oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study subjects receive, in randomized order, either supplementary 30% oxygen or air (21% Oxygen) from a gas tight bag</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>supplementary oxygen during exercise</description>
    <arm_group_label>Supplementary oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic obstructive pulmonary disease

        Exclusion Criteria:

          -  No exacerbation

          -  No active heart disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Edvardsen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LHL Helse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Morten S Ryg, Dr philos</last_name>
    <phone>004793853076</phone>
    <email>morten.ryg@lhl-klinikkene.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne Edvardsen, PhD</last_name>
    <phone>004767058276</phone>
    <email>anne.edvardsen@lhl-klinikkene.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>LHL-klinikkene Glittre</name>
      <address>
        <city>Hakadal</city>
        <state>Akershus</state>
        <zip>1485</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten S Ryg, Dr philos</last_name>
      <phone>004793853076</phone>
      <email>morten.ryg@lhl-klinikkene.no</email>
    </contact>
    <contact_backup>
      <last_name>Anne Edvardsen, PhD</last_name>
      <phone>004767058276</phone>
      <email>anne.edvardsen@lhl-klinikkene.no</email>
    </contact_backup>
    <investigator>
      <last_name>Liv Karin Vesteng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>April 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Anoxia</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
